Pramipexole Completed Phase 4 Trials for Major Depressive Disorder (MDD) Other

IndicationsStatusPurposePhase
CompletedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT02033369Imaging Dopamine Release in Depression